These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 26623998)

  • 1. Identifying Potential Breast Carcinogens: A New Approach.
    Nicole W
    Environ Health Perspect; 2015 Dec; 123(12):A305. PubMed ID: 26623998
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation.
    Schwarzman MR; Ackerman JM; Dairkee SH; Fenton SE; Johnson D; Navarro KM; Osborne G; Rudel RA; Solomon GM; Zeise L; Janssen S
    Environ Health Perspect; 2015 Dec; 123(12):1255-64. PubMed ID: 26032647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenoestrogens, biotransformation, and differential risks for breast cancer.
    Rogan E
    Altern Ther Health Med; 2007; 13(2):S112-21. PubMed ID: 17405688
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Feigelson, H.S. and Henderson, B.E. (1996) Estrogens and breast cancer. Carcinogenesis, 17, 2279-2284.
    Josephy PD
    Carcinogenesis; 1997 Sep; 18(9):1859-60. PubMed ID: 9328188
    [No Abstract]   [Full Text] [Related]  

  • 5. Application of the Margin of Exposure (MOE) approach to substances in food that are genotoxic and carcinogenic: example: CAS No: 105650-23-5 PhIP (2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine).
    Carthew P; DiNovi M; Setzer RW
    Food Chem Toxicol; 2010 Jan; 48 Suppl 1():S98-105. PubMed ID: 20113859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.
    Cavalieri E; Rogan E
    Ann N Y Acad Sci; 2006 Nov; 1089():286-301. PubMed ID: 17261777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New trends in carcinogenic thresholds---International Symposium on "Thresholds for Carcinogens and Mutagens"].
    Hori H; Kitagawa Y
    Shokuhin Eiseigaku Zasshi; 2006 Oct; 47(5):J308-10. PubMed ID: 17128878
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of estrogen-associated carcinogenesis.
    Barrett JC; Tsutsui T
    Prog Clin Biol Res; 1996; 394():105-11. PubMed ID: 8778792
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro toxicity of eight mutagens/carcinogens for three fish cell lines.
    Kocan RM; Landolt ML; Sabo KM
    Bull Environ Contam Toxicol; 1979 Sep; 23(1-2):269-74. PubMed ID: 497437
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of micronucleus tests for screening mutagens and carcinogens].
    Sycheva LP; Zhukov VS
    Vestn Ross Akad Med Nauk; 1997; (7):14-8. PubMed ID: 9324374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender-related differences in response to mutagens and carcinogens.
    Kirsch-Volders M; Bonassi S; Herceg Z; Hirvonen A; Möller L; Phillips DH
    Mutagenesis; 2010 May; 25(3):213-21. PubMed ID: 20194421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA repair in relation to biological monitoring of exposure to mutagens and carcinogens.
    Laval F; Huet J
    IARC Sci Publ; 1984; (59):371-85. PubMed ID: 6545289
    [No Abstract]   [Full Text] [Related]  

  • 13. Estrogens, steroidal.
    National Toxicology Program
    Rep Carcinog; 2002; 10():116-9. PubMed ID: 15323057
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure-activity relationship analysis of rat mammary carcinogens.
    Cunningham AR; Moss ST; Iype SA; Qian G; Qamar S; Cunningham SL
    Chem Res Toxicol; 2008 Oct; 21(10):1970-82. PubMed ID: 18759503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothesis: Activation of rapid signaling by environmental estrogens and epigenetic reprogramming in breast cancer.
    Treviño LS; Wang Q; Walker CL
    Reprod Toxicol; 2015 Jul; 54():136-40. PubMed ID: 25554384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogens, steroidal.
    National Toxicology Program
    Rep Carcinog; 2011; 12():184-8. PubMed ID: 21852836
    [No Abstract]   [Full Text] [Related]  

  • 17. Mutagenic carcinogens and noncarcinogens in transgenic mice.
    Günzel P; Reimann R
    Environ Health Perspect; 1997 Feb; 105(2):163. PubMed ID: 9105788
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship between carcinogenic potency and maximum tolerated dose is similar for mutagens and nonmutagens.
    Goodman G; Shlyakhter A; Wilson R
    Prog Clin Biol Res; 1991; 369():501-16. PubMed ID: 1946542
    [No Abstract]   [Full Text] [Related]  

  • 19. Report of ICPEMC Task Group 5 on the differentiation between genotoxic and non-genotoxic carcinogens.
    Mutat Res; 1984 Jan; 133(1):1-49. PubMed ID: 6363908
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dichlorodiphenyltrichloroethane (DDT) and its metabolites: hormone-like and carcinogenic properties].
    Turusov VS; Rakitskiĭ VN; Tomatis L
    Vopr Onkol; 2003; 49(3):257-60. PubMed ID: 12926206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.